3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA

Temas de la conferencia
Be at the forefront of the insights from 60+ leading experts as they share their learnings on:

Commercialization challenges, the payers perspective and the investors' criteria for business in the current and future NASH market

The non-invasive diagnostics landscape and regulatory considerations on biomarker adoption for clinical trials

Computational methods and artificial intelligence to increase the efficiency of drug development

Organizador profesional (PCO)
Hanson Wade

https://go.evvnt.com/296641-0?pid=4832

Ms. Georgina FitzGerald